Houston Biotech Considering HQ Move To SA

Dated: 05/25/2018

Views: 7

Image title

San Antonio is courting a Houston-based biotech company that is considering moving its headquarters to the Alamo City.

Kiromic Inc., a clinical-stage company, is evaluating whether to shift its operations 200 miles west. San Antonio City Council is scheduled to vote May 31 on whether to authorize the San Antonio Economic Development Corp., or SAEDC, to enter into an economic development agreement with Kiromic. The deal for council members to consider involves a $200,000 grant for the Houston company in return for moving its headquarters and business operations to San Antonio this year.

Under the proposed deal, Kiromic would need to keep its operations in the Alamo City for at least five years. In addition, it would need to create and retain up to 20 jobs.

Kiromic's Houston office is in the Texas Medical Center at 7707 Fannin St., according to its website.

Mayor Ron Nirenberg said Kiromic is an attractive target because it’s an innovative biotech company that would bring drug research, development and manufacturing to San Antonio. It would move Phase I and II clinical trials to the Alamo City.

San Antonio City Manager Sheryl Sculley said SAEDC officials and other community leaders “have worked diligently to recruit Kiromic to San Antonio.”

Sculley is confident the company will move here if council members approve the incentive deal, under which the SAEDC would get $200,000 of Series A preferred shares in Kiromic.

Founded in 2012, Kiromic is focused on developing the next generation of immunotherapy treatments for cancer and other diseases. The company is seeking to raise $12 million in Series A funding while it contemplates a possible move.

“Kiromic is certainly impressed by what the San Antonio community has to offer our bioscience company, particularly a collaborative ecosystem to continue our research, manufacturing and clinical trials,” Kiromic CEO Maurizio Chiriva Internati said in a statement.

Kiromic is already conducting some of its Phase I clinical trials in San Antonio as it evaluates potential new homes for the company.

“We believe San Antonio presents the best opportunity for our company to succeed in bringing revolutionary immunotherapy drugs to market,” Internati said.

 The company plans to decide in 60 to 90 days on whether to move.

Blog author image

Jared Anthony

As a full time professional real estate agent & former airline pilot, I pride myself on offering superior personal service before, during and after your transaction. Knowledge, commitment, honesty, ex....

Want to Advertise on this Site?

Latest Blog Posts

Did Tax Reform Kill The Luxury Market NOT SO FAR

The new tax code limits the deduction of state and local property taxes, as well as income or sales taxes, to a total of $10,000. When the tax reform legislation was put into law at the beginning of

Read More

Do Not Mess With Texas Its Population Is The Fastest Growing In The US

Texas and its strong business engine seem to be successfully wooing growing numbers of the population to its larger cities such as San Antonio, Dallas, and Fort Worth.According to a recent U.S.

Read More

Why Real Estate Is Everything I Love About Pride Month

Historically, the real estate industry has been — and continues to be — a bellwether for socio-political changeBY ELIZABETH ANN STRIBLING-KIVLANAs June is National Pride Month, I want to take a

Read More

Valero Faces Permit Fight Over Emissions At Houston Refinery

Enlarge San Antonio-based refining company Valero Energy Corp. wants to add hydrogen cyanide to the list of emissions from its Houston refinery. VALERO ENERGY CORP. IN THIS

Read More